Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-12 Purchase |
2023-06-14 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
28,000 | $0.35086 | $9,824 | 94,726 (Direct) |
View |
| 2023-04-13 Purchase |
2023-04-17 06:00 am |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
150,000 | $0.29286 | $43,930 | 763,176 (Indirect Direct) |
View |
| 2023-04-12 Purchase |
2023-04-14 6:02 pm |
Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer |
25,000 | $0.288 | $7,200 | 164,676 (Direct) |
View |
| 2023-04-12 Purchase |
2023-04-14 06:00 am |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
25,000 | $0.29 | $7,250 | 106,901 (Direct) |
View |
| 2023-04-13 Purchase |
2023-04-14 06:00 am |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
30,000 | $0.2987 | $8,961 | 163,219 (Indirect Direct) |
View |
| 2022-03-24 Purchase |
2022-03-28 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
5,000 | $1.4421 | $7,210 | 94,522 (Indirect Direct) |
View |
| 2022-01-27 Purchase |
2022-01-31 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
12,500 | $1.73 | $21,625 | 89,522 (Indirect Direct) |
View |
| 2022-01-27 Purchase |
2022-01-31 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
13,500 | $1.7244 | $23,280 | 44,867 (Direct) |
View |
| 2022-01-27 Purchase |
2022-01-31 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer |
10,000 | $1.69 | $16,900 | 67,137 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-28 Option Award |
2023-06-30 4:00 pm |
N/A 2033-06-28 |
Oncternal Therapeutics Inc. | ONCT | DeSimone Jill Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-24 4:00 pm |
N/A 2033-02-21 |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
757,196 | $0 | 757,196 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:01 pm |
N/A 2033-02-21 |
Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:01 pm |
N/A 2033-02-21 |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
210,000 | $0 | 210,000 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:00 pm |
N/A 2033-02-21 |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:00 pm |
N/A 2033-02-21 |
Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technology Officer |
220,000 | $0 | 220,000 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:00 pm |
N/A 2033-02-21 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-05 6:02 pm |
N/A 2033-01-04 |
Oncternal Therapeutics Inc. | ONCT | DeSimone Jill Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2023-01-05 6:01 pm |
N/A 2032-06-22 |
Oncternal Therapeutics Inc. | ONCT | DeSimone Jill Director |
0 | $0 | 10,000 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technology Officer |
6,238 | $1.02 | 66,754 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
29,118 | $1.02 | 613,176 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
6,091 | $1.02 | 81,901 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
6,266 | $1.02 | 66,726 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer |
9,961 | $1.02 | 139,676 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-05 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
4,428 | $1.02 | 133,219 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 6:22 pm |
N/A 2032-07-28 |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
71,875 | $0 | 116,742 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 6:21 pm |
N/A 2032-07-28 |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
71,875 | $0 | 101,742 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 6:20 pm |
N/A 2032-07-28 |
Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technology Officer |
71,875 | $0 | 101,742 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 6:19 pm |
N/A 2032-07-28 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
71,875 | $0 | 166,397 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 6:18 pm |
N/A 2032-07-28 |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
340,625 | $0 | 778,544 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 6:16 pm |
N/A 2032-07-28 |
Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer |
137,500 | $0 | 204,637 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:01 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:00 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | CARTER MICHAEL G Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:00 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | KISNER DANIEL L Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:00 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | MAZANET ROSEMARY Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:00 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | Chen Jinzhu PhD Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:00 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | Nakanishi Xin Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:00 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | Wills Robert James Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:00 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | LARUE WILLIAM R Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 6:00 pm |
N/A 2032-06-16 |
Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-10-01 Ownership |
2022-02-11 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director |
125,000 | $0 | 606,498 (Indirect) |
View |
Ownership |
2022-02-11 6:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director |
0 | $0 | 606,498 (Indirect) |
View |